Ownership history in CITIGROUP INC · 9 quarters on record
This page tracks every 13F SEC filing in which CITIGROUP INC reported a position in ESTRELLA IMMUNOPHARMA INC (ESLAW). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | UNCHANGED | 30,000 | — | 0% | 0.00% | $2K | — |
| 2025 Q3 | UNCHANGED | 30,000 | — | 0% | 0.00% | $2K | — |
| 2025 Q2 | UNCHANGED | 30,000 | — | 0% | 0.00% | $1K | — |
| 2025 Q1 | UNCHANGED | 30,000 | — | 0% | 0.00% | $2K | — |
| 2024 Q4 | UNCHANGED | 30,000 | — | 0% | 0.00% | $3K | — |
| 2024 Q3 | UNCHANGED | 30,000 | — | 0% | 0.00% | $2K | — |
| 2024 Q2 | UNCHANGED | 30,000 | — | 0% | 0.00% | $2K | — |
| 2024 Q1 | UNCHANGED | 30,000 | — | 0% | 0.00% | $2K | — |
| 2023 Q4 | INITIATED | 30,000 | — | — | 0.00% | $900 | — |
As of 2025 Q4 — sorted by position size